U.S. market Closed. Opens in 5 hours 57 minutes

SWAV | ShockWave Medical, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for SWAV we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is wealthy, Growth is exceptionally good and Health is strong.

Valuation (17%)

Company Industry
P/E Ratio (TTM) 76.34 47.85
PEG Ratio (TTM) 6.73 -0.77
P/S Ratio (TTM) 15.95 6.10
P/B Ratio (TTM) 16.60 6.12
P/FCF Ratio (TTM) 75.65 42.18
Price to 5YR AVG Earnings Ratio 296.50 59.80
Price to 5YR AVG FCF Ratio 498.59 34.34

Profitability (65%)

Company Industry
ROA (TTM) 9.95% 5.29%
ROE (TTM) 24.79% 27.69%
Net Profit Margin (TTM) 20.75% 7.92%
ROIC 5YR AVG 8.58% 6.68%

Growth (97%)

4QTR AVG 3YR AVG 5YR AVG
EPS 10.93% 18.03% 487.21%
Revenue 8.01% 185.93% 142.68%
Net Income 11.64% 11.07% 493.12%
Cash Flow 9.00% 19.05% 161.33%

Health (65%)

Company Industry
Current Ratio (TTM) 13.81 2.88
Quick Ratio (TTM) 12.49 2.15
D/E Ratio (TTM) 1.03 0.62
Interest Coverage (TTM) 17.69 23.32
Piotroski F-Score 6 6
Altman Z-Score 10.32 7.57
LTL to 5YR AVG FCF 29.03 3.50
Shares Outstanding Growth 5YR AVG 7.57% 1.64%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙